702 related articles for article (PubMed ID: 30423294)
1. Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Jones CL; Stevens BM; D'Alessandro A; Reisz JA; Culp-Hill R; Nemkov T; Pei S; Khan N; Adane B; Ye H; Krug A; Reinhold D; Smith C; DeGregori J; Pollyea DA; Jordan CT
Cancer Cell; 2018 Nov; 34(5):724-740.e4. PubMed ID: 30423294
[TBL] [Abstract][Full Text] [Related]
2. Extinguishing the Embers: Targeting AML Metabolism.
Culp-Hill R; D'Alessandro A; Pietras EM
Trends Mol Med; 2021 Apr; 27(4):332-344. PubMed ID: 33121874
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia-driven IL-3-dependent upregulation of BCL2 in non-malignant hematopoietic stem and progenitor cells increases venetoclax-induced cytopenias.
Fowler-Shorten DJ; Maynard RS; Hampton K; Altera A; Markham M; Ehikioya M; Wojtowicz EE; Bowles KM; Rushworth SA; Hellmich C
Haematologica; 2024 May; 109(5):1576-1581. PubMed ID: 38186347
[No Abstract] [Full Text] [Related]
4. LAIR-1 agonism as a therapy for acute myeloid leukemia.
Lovewell RR; Hong J; Kundu S; Fielder CM; Hu Q; Kim KW; Ramsey HE; Gorska AE; Fuller LS; Tian L; Kothari P; Paucarmayta A; Mason EF; Meza I; Manzanarez Y; Bosiacki J; Maloveste K; Mitchell N; Barbu EA; Morawski A; Maloveste S; Cusumano Z; Patel SJ; Savona MR; Langermann S; Myint H; Flies DB; Kim TK
J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37966113
[TBL] [Abstract][Full Text] [Related]
5. circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
Yang X; Liu J; Liu W; Wu H; Wei Y; Guo X; Jia H; Can C; Wang D; Hu X; Ma D
Leukemia; 2024 May; 38(5):1057-1071. PubMed ID: 38424136
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia.
de Beauchamp L; Himonas E; Helgason GV
Leukemia; 2022 Jan; 36(1):1-12. PubMed ID: 34561557
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia.
Singh P; Murali R; Shanmugam SG; Thomas S; Scott J; Warrier S; Arfuso F; Dharmarajan A; Gandhirajan RK
Stem Cells; 2024 Mar; 42(3):200-215. PubMed ID: 38167958
[TBL] [Abstract][Full Text] [Related]
8. SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Xu X; Yu Y; Zhang W; Ma W; He C; Qiu G; Wang X; Liu Q; Zhao M; Xie J; Tao F; Perry JM; Liu Q; Rao S; Kang X; Zhao M; Jiang L
Nat Cell Biol; 2024 Mar; 26(3):464-477. PubMed ID: 38321204
[TBL] [Abstract][Full Text] [Related]
9. The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia.
Su Y; Carter JL; Li X; Fukuda Y; Gray A; Lynch J; Edwards H; Ma J; Schreiner P; Polin L; Kushner J; Dzinic SH; Buck SA; Pruett-Miller SM; Hege-Hurrish K; Robinson C; Qiao X; Liu S; Wu S; Wang G; Li J; Allen JE; Prabhu VV; Schimmer AD; Joshi D; Kalhor-Monfared S; Watson IDG; Marcellus R; Isaac MB; Al-Awar R; Taub JW; Lin H; Schuetz JD; Ge Y
Cancer Res; 2024 Apr; 84(7):1084-1100. PubMed ID: 38266099
[TBL] [Abstract][Full Text] [Related]
10. GPRC5C drives branched-chain amino acid metabolism in leukemogenesis.
Zhang YW; Velasco-Hernandez T; Mess J; Lalioti ME; Romero-Mulero MC; Obier N; Karantzelis N; Rettkowski J; Schönberger K; Karabacz N; Jäcklein K; Morishima T; Trincado JL; Romecin P; Martinez A; Takizawa H; Shoumariyeh K; Renders S; Zeiser R; Pahl HL; Béliveau F; Hébert J; Lehnertz B; Sauvageau G; Menendez P; Cabezas-Wallscheid N
Blood Adv; 2023 Dec; 7(24):7525-7538. PubMed ID: 37639313
[TBL] [Abstract][Full Text] [Related]
11. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
Sheth AI; Althoff MJ; Tolison H; Engel K; Amaya ML; Krug AE; Young TN; Minhajuddin M; Pei S; Patel SB; Winters A; Miller R; Shelton IT; St-Germain J; Ling T; Jones CL; Raught B; Gillen AE; Ransom M; Staggs S; Smith CA; Pollyea DA; Stevens BM; Jordan CT
Cancer Discov; 2024 May; ():. PubMed ID: 38787341
[TBL] [Abstract][Full Text] [Related]
12. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
Sheth AI; Engel K; Tolison H; Althoff MJ; Amaya ML; Krug A; Young T; Pei S; Patel SB; Minhajuddin M; Winters A; Miller R; Shelton I; St-Germain J; Ling T; Jones C; Raught B; Gillen A; Ransom M; Staggs S; Smith CA; Pollyea DA; Stevens BM; Jordan CT
bioRxiv; 2023 Oct; ():. PubMed ID: 37873284
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Plasticity of Acute Myeloid Leukemia.
Kreitz J; Schönfeld C; Seibert M; Stolp V; Alshamleh I; Oellerich T; Steffen B; Schwalbe H; Schnütgen F; Kurrle N; Serve H
Cells; 2019 Jul; 8(8):. PubMed ID: 31370337
[TBL] [Abstract][Full Text] [Related]
14. The paradox of metabolism in quiescent stem cells.
Coller HA
FEBS Lett; 2019 Oct; 593(20):2817-2839. PubMed ID: 31531979
[TBL] [Abstract][Full Text] [Related]
15. Autophagy maintains tumour growth through circulating arginine.
Poillet-Perez L; Xie X; Zhan L; Yang Y; Sharp DW; Hu ZS; Su X; Maganti A; Jiang C; Lu W; Zheng H; Bosenberg MW; Mehnert JM; Guo JY; Lattime E; Rabinowitz JD; White E
Nature; 2018 Nov; 563(7732):569-573. PubMed ID: 30429607
[TBL] [Abstract][Full Text] [Related]
16. Mannose impairs tumour growth and enhances chemotherapy.
Gonzalez PS; O'Prey J; Cardaci S; Barthet VJA; Sakamaki JI; Beaumatin F; Roseweir A; Gay DM; Mackay G; Malviya G; Kania E; Ritchie S; Baudot AD; Zunino B; Mrowinska A; Nixon C; Ennis D; Hoyle A; Millan D; McNeish IA; Sansom OJ; Edwards J; Ryan KM
Nature; 2018 Nov; 563(7733):719-723. PubMed ID: 30464341
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Shifrut E; Carnevale J; Tobin V; Roth TL; Woo JM; Bui CT; Li PJ; Diolaiti ME; Ashworth A; Marson A
Cell; 2018 Dec; 175(7):1958-1971.e15. PubMed ID: 30449619
[TBL] [Abstract][Full Text] [Related]
18. Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer.
Zhang H; Pandey S; Travers M; Sun H; Morton G; Madzo J; Chung W; Khowsathit J; Perez-Leal O; Barrero CA; Merali C; Okamoto Y; Sato T; Pan J; Garriga J; Bhanu NV; Simithy J; Patel B; Huang J; Raynal NJ; Garcia BA; Jacobson MA; Kadoch C; Merali S; Zhang Y; Childers W; Abou-Gharbia M; Karanicolas J; Baylin SB; Zahnow CA; Jelinek J; Graña X; Issa JJ
Cell; 2018 Nov; 175(5):1244-1258.e26. PubMed ID: 30454645
[TBL] [Abstract][Full Text] [Related]
19. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
Hinohara K; Wu HJ; Vigneau S; McDonald TO; Igarashi KJ; Yamamoto KN; Madsen T; Fassl A; Egri SB; Papanastasiou M; Ding L; Peluffo G; Cohen O; Kales SC; Lal-Nag M; Rai G; Maloney DJ; Jadhav A; Simeonov A; Wagle N; Brown M; Meissner A; Sicinski P; Jaffe JD; Jeselsohn R; Gimelbrant AA; Michor F; Polyak K
Cancer Cell; 2018 Dec; 34(6):939-953.e9. PubMed ID: 30472020
[TBL] [Abstract][Full Text] [Related]
20. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism.
Kory N; Wyant GA; Prakash G; Uit de Bos J; Bottanelli F; Pacold ME; Chan SH; Lewis CA; Wang T; Keys HR; Guo YE; Sabatini DM
Science; 2018 Nov; 362(6416):. PubMed ID: 30442778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
